TipRanks
Dermapharm Holding SE (CH:DMP)
:DMP
Switzerland Market
DMP
Dermapharm Holding SE
RESEARCH TOOLSreports

Dermapharm Holding SE (DMP) Stock News & Sentiment

0 Followers
Dermapharm Rated Hold as Growth Normalizes and Risks Temper Upside; Price Target Reiterated at $44
Premium
Ratings
Dermapharm Rated Hold as Growth Normalizes and Risks Temper Upside; Price Target Reiterated at $44
1M ago
Dermapharm: Improving Margins but Modest Growth Outlook Leads Piasta to Reiterate Hold and Maintain $44 Price Target
Premium
Ratings
Dermapharm: Improving Margins but Modest Growth Outlook Leads Piasta to Reiterate Hold and Maintain $44 Price Target
1M ago
Dermapharm: Hold Rating Reiterated as Execution Risks Temper Growth Outlook; Price Target Maintained at $44
Premium
Ratings
Dermapharm: Hold Rating Reiterated as Execution Risks Temper Growth Outlook; Price Target Maintained at $44
2M ago
Hold Rating Maintained as Results Track Guidance; €44 Price Target Kept Unchanged
Premium
Ratings
Hold Rating Maintained as Results Track Guidance; €44 Price Target Kept Unchanged
2M ago
Is DMP a Buy, Before Earnings?
Premium
Pre-Earnings
Is DMP a Buy, Before Earnings?
5M ago
Fabian Piasta Reiterates Hold Rating and Keeps $34 Price Target as Improved Profitability Aligns With Expectations
Premium
Ratings
Fabian Piasta Reiterates Hold Rating and Keeps $34 Price Target as Improved Profitability Aligns With Expectations
5M ago
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
Premium
Ratings
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
6M ago
More CH:DMP News >

DMP News on the Web

Dermapharm Holding (XTRA:DMP) Posted Stronger Half Year Results, Does The Valuation Still Look Cheap?
Simply Wall St
Bullish
Dermapharm Rated Hold as Growth Normalizes and Risks Temper Upside; Price Target Reiterated at $44
TipRanks News
Neutral
Be Sure To Check Out Dermapharm Holding SE (ETR:DMP) Before It Goes Ex-Dividend
Simply Wall St
Bullish
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
TipRanks News
Neutral
Hold Rating Maintained on Dermapharm as Profitability Gains Offset by Weak Top-Line Momentum and Limited Near-Term Upside
TipRanks News
Bearish
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Simply Wall St
Neutral
Despite delivering investors losses of 22% over the past 5 years, Dermapharm Holding (ETR:DMP) has been growing its earnings
Simply Wall St
Bullish
Getting In Cheap On Dermapharm Holding SE (ETR:DMP) Might Be Difficult
Simply Wall St
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is CH:DMP’s Media Buzz Sentiment?
Currently, no data Available
What is CH:DMP’s weekly average amount of articles?
In an average week, 1.5 articles about CH:DMP are published.
    What is CH:DMP’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    RHHBYRoche Holding
    BAYRYBayer
    SNYSanofi
    CICigna
    TFXTeleflex
    Showing the stocks with the most bullish news sentiment over the past week